Free Cortisol and Free 21-Deoxycortisol in the Clinical Evaluation of Congenital Adrenal Hyperplasia
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgae591 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Bas P H Adriaansen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Hydrocortisone, Cortodoxone. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International Fund Congenital Adrenal Hyperplasia.
Abstract (Originalsprache)
Context
Some patients with classic congenital adrenal hyperplasia (CAH) survive without glucocorticoid treatment. Increased precursor concentrations in these patients might lead to higher free (biological active) cortisol concentrations by influencing cortisol–protein binding. In 21-hydroxylase deficiency (21OHD), the most common CAH form, accumulated 21-deoxycortisol (21DF) may further increase glucocorticoid activity. Both mechanisms could explain the low occurrence of symptoms in some patients with untreated classic CAH.
Objective
Develop and validate a liquid chromatography tandem mass spectrometry (LC-MS/MS) method for free cortisol and free 21DF to quantify these steroids in patients with untreated classic CAH before and after Synacthen administration, and compare these concentrations to concentrations measured in patients with nonclassic CAH (NCCAH), other forms of adrenal insufficiency (AI), and controls.
Methods
An LC-MS/MS method to measure free cortisol and free 21DF was developed and validated. Total and free serum concentrations of both cortisol and 21DF were measured in patients with untreated classic CAH (n = 29), NCCAH (n = 5), AI (n = 3), and controls (n = 11) before and 60 minutes after stimulation with Synacthen.
Results
Unstimulated total cortisol concentrations of patients with untreated classic CAH (median 109 nmol/L) were lower than in patients with untreated NCCAH (249 nmol/L, P = .010) and controls (202 nmol/L, P = .016), but free cortisol concentrations were similar. Basal free 21DF concentrations were high in patients with 21OHD (median 5.32 nmol/L) and undetectable in patients with AI and controls (<0.19 nmol/L). After Synacthen administration, free 21DF concentrations increased in patients with 21OHD, while free cortisol concentrations did not change.
Conclusion
Free cortisol concentrations in patients with classic CAH were similar to those in controls and patients with NCCAH, indicating comparable cortisol availability. Additionally, patients with 21OHD produce high concentrations of 21DF, possibly explaining the low occurrence of symptoms in some patients with classic 21OHD. Free cortisol and 21DF levels should be considered in evaluating adrenal insufficiency in patients with CAH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands.
- Department of Pediatrics, Division of Pediatric Endocrinology, Amalia Children's Hospital, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands.
- Department of Pediatrics, Division of Pediatric Endocrinology, Faculty of Medicine, Diponegoro University, Jawa Tengah 50275, Semarang, Indonesia.
- Department of Pediatrics, Canisius Wilhelmina Hospital, 6532 SZ Nijmegen, the Netherlands.
- Department of Pediatrics, Division of Pediatric Endocrinology, MosaKids Children's Hospital, Maastricht University Medical Centre+, 6229 HX Maastricht, the Netherlands.
- Department of Radiation Oncology, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands.
ORCID-Profile: Bas P H Adriaansen, Agustini Utari, André J Olthaar, Paul N Span, Fred C G J Sweep, Hedi L Claahsen-van der Grinten, Antonius E van Herwaarden
Förderung
- International Fund Congenital Adrenal Hyperplasia
Zitieren
APA
Adriaansen, B. P. H., Utari, A., Olthaar, A. J., van der Steen, R. C. B. M., Pijnenburg-Kleizen, K. J., Berkenbosch, L., Span, P. N., Sweep, F. C. G. J., Claahsen-van der Grinten, H. L., & van Herwaarden, A. E. (2025). Free Cortisol and Free 21-Deoxycortisol in the Clinical Evaluation of Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae591
Vancouver
Adriaansen BPH, Utari A, Olthaar AJ, van der Steen RCBM, Pijnenburg-Kleizen KJ, Berkenbosch L, et al. Free Cortisol and Free 21-Deoxycortisol in the Clinical Evaluation of Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae591
BibTeX
@article{Adriaansen2025,
author = {Adriaansen, Bas P H and Utari, Agustini and Olthaar, André J and van der Steen, Rob C B M and Pijnenburg-Kleizen, Karijn J and Berkenbosch, Lizanne and Span, Paul N and Sweep, Fred C G J and Claahsen-van der Grinten, Hedi L and van Herwaarden, Antonius E},
title = {Free Cortisol and Free 21-Deoxycortisol in the Clinical Evaluation of Congenital Adrenal Hyperplasia},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgae591}
}
EUVIMED